Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C3orf14 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | SIRT6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | HSD17B7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | SHISA7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | PRR25 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | ROMO1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | HIGD1A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | NOTCH2NL | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | TBC1D14 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | OR10G6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |